Suppr超能文献

肉毒杆菌毒素作为美国军队慢性运动性骨筋膜室综合征的一种新型治疗方法。

Botulinum Toxin as a Novel Treatment for Chronic Exertional Compartment Syndrome in the U.S. Military.

作者信息

Hutto Wesley M, Schroeder Paul B, Leggit Jeffery C

机构信息

School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD.

Department of Family Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD.

出版信息

Mil Med. 2019 May 1;184(5-6):e458-e461. doi: 10.1093/milmed/usy223.

Abstract

Chronic exertional compartment syndrome (CECS) is a debilitating condition that is not uncommon in athletes and military service members. The only curative treatment for this condition, surgical fascial release, was first described in 1956. In the ensuing 62 years, this has remained the standard therapy despite symptom recurrence in 45% of military service members who underwent surgery. In 2013, a case series introduced intracompartmental injections of botulinum toxin A as a non-surgical treatment option for CECS, which proved effective in 15 out of 16 patients. In this case report, we present the case of a U.S. military service member treated with BoNT-A for bilateral lower leg CECS. This patient remains pain free at 11 months after initial treatment. This case, coupled with previously published cases series, demonstrates the potential of this novel treatment as a long-term, non-surgical alternative for CECS in the U.S. military population.

摘要

慢性运动性骨筋膜室综合征(CECS)是一种使人衰弱的病症,在运动员和军人中并不罕见。针对这种病症的唯一治愈性治疗方法——手术筋膜松解术,于1956年首次被描述。在随后的62年里,尽管接受手术的军人中有45%出现症状复发,但这仍然是标准治疗方法。2013年,一个病例系列介绍了在骨筋膜室内注射A型肉毒杆菌毒素作为CECS的一种非手术治疗选择,16例患者中有15例证明有效。在本病例报告中,我们介绍了一名接受A型肉毒杆菌毒素治疗双侧小腿CECS的美国军人的病例。该患者在初始治疗11个月后仍无疼痛。该病例与先前发表的病例系列相结合,证明了这种新治疗方法作为美国军人CECS的长期非手术替代方法的潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验